BIOMAT Database Logo BIOMAT Database Logo

[Treatment of clinical stages I and II of Hodgkin's disease]. 1977

M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier

UI MeSH Term Description Entries
D008297 Male Males
D008482 Mediastinum A membrane in the midline of the THORAX of mammals. It separates the lungs between the STERNUM in front and the VERTEBRAL COLUMN behind. It also surrounds the HEART, TRACHEA, ESOPHAGUS, THYMUS, and LYMPH NODES.
D009026 Mortality All deaths reported in a given population. CFR Case Fatality Rate,Crude Death Rate,Crude Mortality Rate,Death Rate,Age Specific Death Rate,Age-Specific Death Rate,Case Fatality Rate,Decline, Mortality,Determinants, Mortality,Differential Mortality,Excess Mortality,Mortality Decline,Mortality Determinants,Mortality Rate,Mortality, Differential,Mortality, Excess,Age-Specific Death Rates,Case Fatality Rates,Crude Death Rates,Crude Mortality Rates,Death Rate, Age-Specific,Death Rate, Crude,Death Rates,Determinant, Mortality,Differential Mortalities,Excess Mortalities,Mortalities,Mortality Declines,Mortality Determinant,Mortality Rate, Crude,Mortality Rates,Rate, Age-Specific Death,Rate, Case Fatality,Rate, Crude Death,Rate, Crude Mortality,Rate, Death,Rate, Mortality,Rates, Case Fatality
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D012008 Recurrence The return of a sign, symptom, or disease after a remission. Recrudescence,Relapse,Recrudescences,Recurrences,Relapses
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D005260 Female Females
D006689 Hodgkin Disease A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen. Granuloma, Hodgkin,Granuloma, Malignant,Hodgkin Lymphoma,Lymphogranuloma, Malignant,Granuloma, Hodgkin's,Granuloma, Hodgkins,Hodgkin Lymphoma, Adult,Hodgkin's Disease,Hodgkin's Lymphoma,Hodgkins Disease,Lymphocyte Depletion Hodgkin's Lymphoma,Lymphocyte-Rich Classical Hodgkin's Lymphoma,Mixed Cellularity Hodgkin's Lymphoma,Nodular Lymphocyte-Predominant Hodgkin's Lymphoma,Nodular Sclerosing Hodgkin's Lymphoma,Adult Hodgkin Lymphoma,Disease, Hodgkin,Disease, Hodgkin's,Disease, Hodgkins,Hodgkin Granuloma,Hodgkin's Granuloma,Hodgkins Granuloma,Hodgkins Lymphoma,Lymphocyte Rich Classical Hodgkin's Lymphoma,Lymphogranulomas, Malignant,Lymphoma, Hodgkin,Lymphoma, Hodgkin's,Malignant Granuloma,Malignant Granulomas,Malignant Lymphogranuloma,Malignant Lymphogranulomas,Nodular Lymphocyte Predominant Hodgkin's Lymphoma
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
[Treatment of Hodgkin's disease stages I, II, and III].
January 1977, Nouvelle revue francaise d'hematologie; blood cells,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
[Treatment results of Hodgkin's disease, stages I and II (author's transl)].
May 1981, Klinische Wochenschrift,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
Treatment of Hodgkin's disease stages I and II with chemotherapy alone.
January 1986, Medical and pediatric oncology,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
Treatment of patients with stages I and II nonmediastinal Hodgkin's disease.
December 1982, Cancer,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
Selective splenectomy in Hodgkin's disease, stages I and II. Results of treatment.
December 1978, Israel journal of medical sciences,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
Combined Modality Treatment for Poor Prognosis Stages I and II Hodgkin's Disease.
July 1996, Seminars in radiation oncology,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
Treatment of stages I and II Hodgkin's disease with three different therapeutic modalities.
June 1986, The American journal of medicine,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
A meta-analysis of stages I and II Hodgkin's disease.
March 1990, Cancer,
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
Combination chemotherapy in stages I or II Hodgkin's disease.
November 1979, Lancet (London, England),
M Tubiana, and G Mathé, and M Hayat, and J P le Bourgeois, and M Henry-Amar, and A Laugier
Hodgkin's disease, stages I and II occurring below the diaphragm.
May 1979, Cancer,
Copied contents to your clipboard!